This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Peripheral Arterial Disease
and you are
between 18 and 80
years old
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This study proposes the use of Entresto (sacubitril/valsartan) to test the effects on pain free walking duration on patients with peripheral arterial disease, a condition caused by decreased blood flow to the muscles in the legs.

Provided treatments

  • Drug: Entresto
  • Drug: Placebo group

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02636283. The sponsor of the trial is University of Minnesota and it is looking for 6 volunteers for the current phase.
Official trial title:
Use of Entresto (Sacubitril/Valsartan) for the Treatment of Peripheral Arterial Disease